Determination of the standard deviation for proficiency assessment from past participant’s performances by COTE Isabelle et al.
GENERAL PAPER
Determination of the standard deviation for proficiency
assessment from past participant’s performances
Isabelle Coˆte´ • Piotr Robouch • Benjamin Robouch •
David Bisson • Philippe Gamache • Alain LeBlanc •
Pierre Dumas • Mikae¨l Pedneault
Received: 30 January 2012 / Accepted: 30 May 2012 / Published online: 19 June 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract The ‘‘uncertainty function’’ introduced by
Thompson et al. estimates the reproducibility standard
deviation as a function of concentration or mass fraction.
This model was successfully applied to data derived from
three proficiency testing schemes aiming at the quantifi-
cation of cadmium, lead and mercury in blood and urine.
This model allows the estimation of standard deviation for
the performance assessment for proficiency testing rounds.
Keywords Horwitz equation  Thompson-modified
equation  Uncertainty function  Limit of detection 
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Introduction
The ‘‘Centre de toxicologie du Que´bec’’ (CTQ) [1] belong-
ing to the ‘‘Institut national de sante´ publique du Que´bec’’
(INSPQ) is a public organization that has been offering
human toxicology expertise (environmental, clinical and
occupational) to the provincial health network of Quebec
(Canada) as well as to external clients from around the world.
Since 1979, the CTQ operates several permanent external
quality assessment schemes that enable participating labo-
ratories to evaluate the accuracy and precision of their
analytical methods on a continuous basis. Approximately
250 laboratories from over 30 countries participate in these
proficiency testing (PT) schemes to analyse a wide variety of
elements in biological PT materials of human origin, such as
blood, serum, urine or hair.
In order to verify and further confirm the applicability of
the ‘‘uncertainty function’’ described and discussed in several
publications [2–8], we compiled all the reference values
(XRef) and the corresponding reproducibility standard devia-
tions (sR) determined in the frame of three PT programs
designed for the determination among others of three toxic
trace elements (cadmium, mercury and lead) in blood and
urine matrices. A total of 861 data pairs (XRef, sR)—later
denoted as the CTQ data—were analysed to identify whether
similar trends are observed in the seventeen cases under
investigation (3 PT schemes; 3 elements; 2 matrices; one PT
scheme does not monitor mercury in urine).
Methodology
The experimental data evaluated in this work were reported
in the frame of the three PT programs described hereafter:
• The ‘‘Interlaboratory Comparison Program for metals
in biological matrices’’ (PCI) is a bimonthly scheme
attended by over 130 laboratories applying their routine
analytical techniques;
• The ‘‘Priority Metals Quality Assessment Scheme’’
(PMQAS) is a scheme designed for the US State
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Laboratories, all equipped with the same experimental
instrumentation (inductive coupled plasma mass spec-
trometry, ICP-MS) and applying the same experimental
protocols for the analysis of trace elements in blood and
urine; and
• The ‘‘Quebec Multi-element External Quality Assess-
ment Scheme’’ (QMEQAS) attended by 60 laboratories
using ICP-MS.
At the end of the each PT round, a classical statistical
treatment was applied to the results reported by the par-
ticipants to calculate—after outlier rejection—the median
value and the reproducibility standard deviation (sR). The
median value was set as the assigned reference value
(XRef), while sR was used to derive the standard deviation
for performance assessment (rPT). The CTQ data were
compiled from the previous PT rounds organized by the
CTQ for cadmium, mercury and lead in blood and urine
matrices, as indicated in Table 1. All values were sys-
tematically converted to mass fraction (g g-1).
In the early 1980s, Horwitz et al. [9] reviewed the
reported results in the frame of the Association of Official
Analytical Chemists (AOAC) PT rounds and derived an
empirical relation estimating the coefficient of variation for
the reproducibility (CVR) as a function of the mass fraction
(C) expressed in g g-1:
CVR ¼ 2ð10:5 lg CÞ
.
100 ð1Þ
Twenty years later, Thompson re-evaluated [10]
the results reported in several PT schemes and confirmed
the validity of the Horwitz equation at mass fractions
ranging from 1.2910-7 to 0.138 g g-1, while suggesting a
constant CVR of 0.22 (or 22 %) for mass fractions below
1.2910-7 g g-1.
In order to have a clearer view on how to proceed, we
plotted a set of four graphs for each combination of PT
scheme, element and matrix, namely:
a. CVR versus C, as suggested by Horwitz [9];
b. sR versus C;
c. lg(CVR) versus lg(C), where ‘‘lg’’ denotes the loga-
rithm to base 10; and
d. lg(sR) versus lg(C), as suggested by Thompson [7, 10].
An example of such a set of graphs is shown in Fig. 1a–
d presenting all the data collected in the frame of the
PMQAS round for the determination of cadmium in blood.
A constant CVR of approximately 0.05 is observed at
higher concentration (Fig. 1a)—equivalent to a linear
increase in sR with increasing C (Fig. 1b)—while a con-
stant sR is observed at the lowest mass fraction range
(Fig. 1d). These observations are consistent with the
‘‘uncertainty function’’ introduced by Thompson in 1988
[2] and further discussed since [3–7]:
sR ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a2 þ b2C2
q
ð2Þ
Table 1 Summary of the CTQ data, including the number of data
points (N), the mass fraction ranges investigated (C), the fitted
parameters a, b and calculated ratios a/b, for cadmium, mercury and
lead in urine and blood, assigned in the frame of the PCI, QMEQAS
and PMQAS proficiency testing schemes. The relative standard errors
of the parameters and their ratio are indicated between parentheses
Element Matrix PT N C (g g-1) a (g g-1) b a/b (g g-1)
Cd Blood PCI 63 (0.11–1.5)910-8 2.0910-10 (30 %) 0.084 (17 %) 2.4910-9 (34 %)
PMQAS 75 (0.06–7.9)910-8 1.5910-10 (27 %) 0.054 (15 %) 2.8910-9 (31 %)
QMEQAS 22 (0.05–1.3)910-8 1.5910-10 (36 %) 0.088 (22 %) 1.7910-9 (42 %)
Urine PCI 63 (0.06–1.6)910-8 1.5910-10 (45 %) 0.075 (22 %) 2.0910-9 (50 %)
PMQAS 60 (0.02–1.8)910-8 2.8910-11 (41 %) 0.047 (19 %) 6.0910-10 (45 %)
QMEQAS 24 (0.14–1.3)910-8 1.9910-10 (45 %) 0.075 (18 %) 2.5910-9 (48 %)
Hg Blood PCI 63 (0.18–8.3)910-8 6.4910-10 (27 %) 0.104 (20 %)
PMQAS 75 (0.01–1.2)910-7 3.6910-10 (30 %) 0.052 (18 %) 6.9910-9 (35 %)
QMEQAS 22 (0.15–6.1)910-8 6.7910-10 (37 %) 0.080 (17 %) 8.4910-9 (41 %)
Urine PCI 63 (0.02–2.6)910-7 8.5910-10 (30 %) 0.110 (19 %) 7.7910-9 (36 %)
PMQAS No data
QMEQAS 24 (0.40–9.2)910-8 1.4910-9 (33 %) 0.150 (17 %) 9.3910-9 (37 %)
Pb Blood PCI 63 (0.17–8.4)910-7 3.4910-9 (33 %) 0.067 (17 %) 5.1910-8 (37 %)
PMQAS 75 (0.02–1.4)910-6 3.0910-9 (23 %) 0.049 (21 %) 6.1910-8 (31 %)
QMEQAS 22 (0.24–5.6)910-7 2.4910-9 (31 %) 0.058 (23 %) 4.1910-8 (39 %)
Urine PCI 63 (0.12–7.7)910-7 2.8910-9 (28 %) 0.076 (16 %) 3.7910-8 (32 %)
PMQAS 60 (0.004–4)910-7 – 0.038 (22 %)
QMEQAS 24 (0.02–1.0)910-6 2.7910-9 (23 %) 0.063 (14 %) 4.3910-8 (27 %)
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The function described in Eq. 2 was systematically fit-
ted to the CTQ data. The Newton-Raphson algorithm
implemented in the Microsoft Excel 2010 Solver was
used—without any further data weighting—to minimize
the sum of squares of residuals and to derive the two
parameters a and b. The initial value of parameter b was
set equal to the CVR of the highest mass fraction investi-
gated, while the initial value of parameter a was set to 10-9
by default.
Results and discussion
Neither the Horwitz model nor the Thompson-modified one
fits the CTQ experimental data obtained for cadmium,
mercury or lead. The example for cadmium illustrated in
Fig. 2 clearly shows that most of the data lie below the two
model curves.
One the other hand, the ‘‘uncertainty function’’ (Eq. 2)
fits well the CTQ data. An example is shown in Fig. 1. As
stated by Thompson [8], the ‘‘uncertainty function’’ is
function of parameter a ‘‘[…] describing the constant
variation at concentrations close to the detection limit
[…]’’ and of parameter b representing ‘‘[…] the constant
relative standard deviation at high concentration […].’’ On
the basis of this assumption, an alternative mathematical
approach was derived from Eq. 2, confirmed the values
obtained for a and b, and allowed the estimation of the
respective relative standard errors from the corresponding
variations, which could not be obtained using the MS Excel
2010 Solver. For each PT-matrix-element combination, an
estimate of b was calculated as the average of CVR at the
a b
c d
Fig. 1 The four graphical
representations of the CTQ data
for Cd in blood obtained in the
frame of the PMQAS
proficiency testing scheme:
a CVR versus C; b sR versus C;
c lg(CVR) versus lg(C); and
d lg(sR) versus lg(C). The solid
line represents the ‘‘uncertainty
function’’ fitting the
experimental data points. C and
sR are expressed in g g
-1
Fig. 2 The CTQ data for cadmium in urine (filled symbols) and blood
(empty symbols) assigned in the frame of the PCI (squares), QMEQAS
(circles) and PMQAS (triangles) proficiency testing schemes. Most of
the data lie below the Horwitz (dashed line) and the Thompson-
modified (solid line) model curves. C and sR are expressed in g g
-1
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high concentration range. The mean value of a was then
derived as:
a ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2R  b2C2
q
ð3Þ
When plotting the ‘‘uncertainty function’’ versus mass
fraction, one gets the characteristic shape predicted by
Horwitz [9]—sometimes referred as the ‘‘Horwitz trumpet’’
[11]—and described by Thompson [2]. Figure 1c and d
shows that the ‘‘uncertainty function’’ has two asymptotes—
represented by a constant reproducibility standard deviation,
below a certain mass fraction; while above it, represented
by a constant coefficient of variation of the reproducibility.
The two asymptotes intercept at a mass fraction equal to the
ratio a/b. Table 1 presents the mass fraction ranges, the
values for a, b and the ratio a/b, together with the respective
relative standard errors—provided between parentheses—
for the seventeen PT-matrix-element combinations
investigated.
Reliable b values are determined with a relative stan-
dard error ranging from 14 to 23 %. The b values for the
PMQAS program are systematically the smallest of the
order of 0.05, as expected from a PT scheme having par-
ticipants using the same experimental protocol and the
same instrumentation. The other PT schemes display b
values of 0.07, 0.08 and 0.11 for Pb, Cd and Hg, respec-
tively (Table 1). Koch and Magnusson reported similar
results [12].
Assuming that the ‘‘uncertainty function’’ remains
applicable down to mass fraction close to the limit of
quantification (CLOQ) and to the limit of detection (CLOD)
one could estimate following indicative upper limits:
CLOD ¼ 3a or CLOQ ¼ 10a ð4Þ
Fewer and more scattered data were available for the
determination of a, for which the relative standard errors
ranged from 23 to 45 %. a values of 0.2, 1 and 3 lg kg-1
were obtained for Cd, Hg and Pb, respectively (Table 1).
This would correspond to estimated limits of detection of
0.6, 3 and 9 lg kg-1 in blood and urine matrices. These
limits are well above—up to 20 times—those determined
experimentally for a specific sample treatment and a
dedicated instrumental technique. Such over-estimated
values may be due to the fact that the presented a
values derive from reproducibility standard deviations
(computed from results reported in the frame of several
PT schemes, and obtained using various analytical
methods), whereas CLOD are usually determined under
repeatability conditions.
The ratio a/b for each element from the different
matrices and PT schemes are in agreement within 20 %,
when excluding the value for the PMQAS Cd in urine.
Ratios of the order of 2, 8 and 48 lg kg-1 were obtained
for Cd, Hg and Pb, respectively (Table 1). When combin-
ing with Eq. 4, the following approximations are derived:
a/b & 2CLOQ for b = 0.05 (i.e. PMQAS) or a/b & CLOQ
for b = 0.10 (i.e. PCI or QMEQAS). This indicates that
CTQ might have organized some PT rounds close to the
limit of quantification, below which measurement relative
uncertainties higher than 22 % are to be expected. This
could explain the high scatter of data points at the low
concentration range.
Conclusion
The ‘‘uncertainty function’’ introduced by Thompson et al.
[2] describes well the trend of reproducibility standard
deviation versus mass fraction for cadmium, mercury and
lead in blood and urine samples. The compilation of a and
b calculated using a simple mathematical approach (with-
out any data weighting) will allow CTQ to estimate
reproducibility standards deviations and to derive the
standard deviation of performance assessment (rPT) for
various PT-element-matrix combination. The robust sta-
tistical treatment prescribed by the ISO 13528 guide [13]
would be performed for confirmation. On the other hand,
participants could use the same function to calculate the
reproducibility standard deviation to derive a reasonable
estimate of their measurement uncertainty, as prescribed by
the Eurolab [14]. The CTQ intends to evaluate the
‘‘uncertainty function’’ for the remaining elements and
matrices available.
Furthermore, the CTQ will evaluate the dispatch of iden-
tical PT samples in several PT schemes, using, for example,
the assigned values (XRef, rPT) of one PT round to the other
PTs, similar to what is implemented by the International
Measurement Evaluation Program (IMEP) [15]. This could
significantly reduce the costs for homogeneity and stability
investigation, ensuring the propagation of sound metrological
principle to various groups of participants.
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